Hansa Biopharma AB at TD Cowen Health Care Conference Transcript
(audio in progress) who's joining on the 43rd annual conference. I'm joined by the Hansa Biopharma management team, and I'll pass it over to them to walk through their presentation.
¸ -
Thanks so much for the intro and thank you everyone for your interest in Hansa Biopharma. It's great to be back in real life here at the Cowen conference after a three-year break.
Before I start my presentation, just the usual warning that my presentation today contains forward-looking statements, and therefore, you should apply appropriate caution.
Now, for those of you who are not completely familiar with Hansa Biopharma, here's a snapshot overview of the company. We're founded back in 2007 as a spin out from Lund University in southern Sweden. And what led to the foundation of the company was the discovery of an enzyme which today is known as imlifidase, which has the unique property that it very fast and effectively cleaves immunoglobulin G.
If you
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |